Accolade, Inc is a health information services business based in the US. Accolade shares (ACCD) are listed on the NASDAQ and all prices are listed in US Dollars. Accolade employs 1,720 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Accolade
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ACCD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Accolade stock price (NASDAQ: ACCD)Use our graph to track the performance of ACCD stocks over time.
Accolade shares at a glance
|Latest market close||$50.49|
|52-week range||$29.50 - $65.25|
|50-day moving average||$52.01|
|200-day moving average||$48.78|
|Wall St. target price||$63.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.43|
Buy Accolade shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Accolade stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Accolade price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||-7.12%|
|3 months (2021-04-30)||0.68%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
|Revenue TTM||$194 million|
|Gross profit TTM||$76.7 million|
|Return on assets TTM||-7.82%|
|Return on equity TTM||-42.31%|
|Market capitalisation||$3.2 billion|
TTM: trailing 12 months
Shorting Accolade shares
There are currently 3.4 million Accolade shares held short by investors – that's known as Accolade's "short interest". This figure is 1.7% up from 3.4 million last month.
There are a few different ways that this level of interest in shorting Accolade shares can be evaluated.
Accolade's "short interest ratio" (SIR)
Accolade's "short interest ratio" (SIR) is the quantity of Accolade shares currently shorted divided by the average quantity of Accolade shares traded daily (recently around 610356.660746). Accolade's SIR currently stands at 5.63. In other words for every 100,000 Accolade shares traded daily on the market, roughly 5630 shares are currently held short.
However Accolade's short interest can also be evaluated against the total number of Accolade shares, or, against the total number of tradable Accolade shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Accolade's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Accolade shares in existence, roughly 50 shares are currently held short) or 0.0613% of the tradable shares (for every 100,000 tradable Accolade shares, roughly 61 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Accolade.
Find out more about how you can short Accolade stock.
Accolade share dividends
We're not expecting Accolade to pay a dividend over the next 12 months.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Stocks similar to Accolade
Accolade in the news
Accolade Welcomes Carrot Fertility to the Trusted Supplier Program
Hedge Funds Are Selling Accolade, Inc. (ACCD)
100 Top Growth Stocks Down Big: These 2 Are Worth Considering
Frequently asked questionsWhat percentage of Accolade is owned by insiders or institutions?
Currently 5.787% of Accolade shares are held by insiders and 66.92% by institutions. How many people work for Accolade?
Latest data suggests 1,720 work at Accolade. When does the fiscal year end for Accolade?
Accolade's fiscal year ends in February. Where is Accolade based?
Accolade's address is: 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 What is Accolade's ISIN number?
Accolade's international securities identification number is: US00437E1029 What is Accolade's CUSIP number?
Accolade's Committee on Uniform Securities Identification Procedures number is: M01690102
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert